Work

Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: Support for nigral targeting in Parkinson's disease

Year: 2011

Type: article

Source: Neurobiology of Disease

DOI: 10.1016/j.nbd.2011.05.026

Authors: Raymond T. Bartus, Lamar Brown, Alistair Wilson, Brian Kruegel, Joao Siffert, Eugene M. Johnson, Jeffrey H. Kordower, Christopher D. Herzog

Institutions: Washington University in St. Louis, Rush University Medical Center

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2063711308

FWCI: 4.747

Cites: 68

Cited by: 63

Related to: 10